Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cervical Cancer

Free Subscription 15.09.2025 2 Afr J Prim Health Care Fam Med 2 Am J Case Rep 1 Am J Clin Pathol 1 Anal Sci 1 Ann Behav Med 2 Arch Gynecol Obstet 2 BMJ Open 1 Br J Cancer 1 Brachytherapy 1 Cell Signal 1 Cien Saude Colet 1 Cochrane Database Syst Rev 1 Comput Methods Programs Biomed 2 Cureus 1 Curr Pharm Des 1 Environ Health Prev Med 1 Epidemiol Serv Saude 2 Eur J Obstet Gynecol Reprod Biol 1 Front Immunol 5 Front Oncol 1 Hum Vaccin Immunother 1 Indian J Clin Biochem 3 Int J Cancer 1 Int J Gen Med 1 Int J Gynecol Cancer 1 Int J Radiat Oncol Biol Phys 1 IUBMB Life 1 J Biomed Inform 1 J Cancer Res Clin Oncol 1 J Christ Nurs 1 J Clin Virol 1 J Gynecol Oncol 1 J Infect Dev Ctries 1 J Int Med Res 1 J Obstet Gynaecol Can 1 J Proteome Res 1 J Relig Health 2 J Womens Health (Larchmt) 1 JAMA Netw Open 1 JCO Glob Oncol 1 JMIR Cancer 1 Kaohsiung J Med Sci 1 Medicine (Baltimore) 1 Nutr Clin Pract 1 Obstet Gynecol 1 Oncol Lett 1 Open Med (Wars) 1 Phys Med Biol 2 PLOS Glob Public Health 5 PLoS One 1 Pol Merkur Lekarski 1 Psychooncology 2 Rep Pract Oncol Radiother 1 Rev Cuid 1 Strahlenther Onkol 1 Support Care Cancer 1 Womens Health (Lond) 1 Womens Health Issues

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Afr J Prim Health Care Fam Med

1. NDAKUKAMO EK, Mahalie R, Hailonga-van Dijk P
   Health system constraints in cervical cancer prevention in rural Namibia: A qualitative study.
   Afr J Prim Health Care Fam Med. 2025;17:e1-e9.
   PubMed         Abstract available
   
   
2. POLANE MG, Dlamini SB
   Exploring primary health care nurses' perceptions of cervical cancer screening in Leribe, Lesotho.
   Afr J Prim Health Care Fam Med. 2025;17:e1-e9.
   PubMed         Abstract available
   
   

   
   Am J Case Rep

3. YUAN J, Wang IT, Lin YH, Qiu JT, et al
   Two Cases of Primary Melanoma of the Uterine Cervix.
   Am J Case Rep. 2025;26:e948101.
   PubMed         Abstract available
   
   
4. REN X, Wu J, Yang S, Wang Y, et al
   Radiotherapy-Related Bladder Fistula: A Hidden Cause of Recurrent Abdominal Symptoms.
   Am J Case Rep. 2025;26:e948953.
   PubMed         Abstract available
   
   

   
   Am J Clin Pathol

5. DOXTADER EE, Ooms K, Brainard JA, Policarpio-Nicolas MLC, et al
   Papanicolaou test interpretation utilizing the Hologic Genius Digital Diagnostics System vs manual glass slide review: A retrospective study of 596 cases.
   Am J Clin Pathol. 2025;164:513-521.
   PubMed         Abstract available
   
   

   
   Anal Sci

6. LIN M, Zou Y, Yu L, Xiao H, et al
   An immunoassay based on polyHRP signal amplification for HPV16/18 E6 RNA detection with anti-DNA-RNA hybrid antibody.
   Anal Sci. 2025;41:1461-1471.
   PubMed         Abstract available
   
   

   
   Ann Behav Med

7. HUA J, Klein WMP, Acevedo AM
   Sociocultural correlates of cervical cancer prevention behaviors among Hispanic/Latina women in the United States.
   Ann Behav Med. 2025;59:kaaf069.
   PubMed         Abstract available
   
   

   
   Arch Gynecol Obstet

8. VAN COOTEN VV, van Hamont D, Siebers AG, Alcala L, et al
   The prevalence and clinical relevance of cervical abnormalities after an amputation of the cervix as part of prolapse surgery: a cross-sectional study.
   Arch Gynecol Obstet. 2025;312:1287-1294.
   PubMed         Abstract available
   
   
9. EHLERS U, Hoischen L, Stalp JL, Hachenberg J, et al
   The treatment of cervical intraepithelial neoplasia grade 2 (HSIL): between active surveillance and surgery-a 10-year monocentric data analysis.
   Arch Gynecol Obstet. 2025;312:1125-1132.
   PubMed         Abstract available
   
   

   
   BMJ Open

10. CHONG L, Zou Z, Xia L, Wang X, et al
    p16 expression and its correlation with the clinical pathological characteristics of patients with cervical cancer: a systematic review and meta-analysis.
    BMJ Open. 2025;15:e102602.
    PubMed         Abstract available
    
    
11. LEMA TF, Mosalo A, Moleki M
    Perceived risk of human papillomavirus infection and cervical cancer: a qualitative study among Ethiopian women.
    BMJ Open. 2025;15:e103895.
    PubMed         Abstract available
    
    

    
    Br J Cancer

12. GORI S, Venturelli F, Carozzi F, Giorgi Rossi P, et al
    Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology.
    Br J Cancer. 2025 Sep 11. doi: 10.1038/s41416-025-03161.
    PubMed         Abstract available
    
    

    
    Brachytherapy

13. KOMORI S, Takagawa Y, Sato H, Machida M, et al
    A novel dose-based intra-preplan method for high-dose-rate brachytherapy in cervical cancer using modeling and optimization algorithms.
    Brachytherapy. 2025 Sep 6:S1538-4721(25)00250.
    PubMed         Abstract available
    
    

    
    Cell Signal

14. AN S, Han A, Lin Z, Quan H, et al
    Targeting ferroptosis in cervical cancer: Mechanistic insights and therapeutic opportunities.
    Cell Signal. 2025 Sep 10:112122. doi: 10.1016/j.cellsig.2025.112122.
    PubMed         Abstract available
    
    

    
    Cien Saude Colet

15. VIEIRA JR, Azize R, Nucci MF
    [Between gender and health technologies: an analysis of HPV and cervical cancer prevention campaigns from 2014 to 2020].
    Cien Saude Colet. 2025;30:e04072024.
    PubMed         Abstract available
    
    

    
    Cochrane Database Syst Rev

16. KAPP P, Schmucker C, Siemens W, Brugger T, et al
    Human papillomavirus (HPV) vaccination in women with conisation.
    Cochrane Database Syst Rev. 2025;9:CD016121.
    PubMed         Abstract available
    
    

    
    Comput Methods Programs Biomed

17. KHARE SK, Booth BB, Blanes-Vidal V, Petersen LK, et al
    An explainable attention model for cervical precancer risk classification using colposcopic images.
    Comput Methods Programs Biomed. 2025;271:108976.
    PubMed         Abstract available
    
    

    
    Cureus

18. VERMA R, Sharma R, Mishra P, Mishra N, et al
    Opportunistic Cervical Cancer Screening During Antenatal Visits: A Small Step Toward Early Detection.
    Cureus. 2025;17:e89433.
    PubMed         Abstract available
    
    
19. YADAV J, Gupta S, Venugopal AK, Ghosh A, et al
    3D Conformal Radiotherapy Versus the Conventional Box Technique for Cervical Cancer: A Dosimetric Observational Study.
    Cureus. 2025;17:e89799.
    PubMed         Abstract available
    
    

    
    Curr Pharm Des

20. ZOGHEBI K, Jali AM
    Flavonoids as Dual Inhibitors of MELK and LYN Kinases in Cervical Cancer: An In Silico Molecular Docking Analysis.
    Curr Pharm Des. 2025 Sep 5. doi: 10.2174/0113816128387273250823102532.
    PubMed         Abstract available
    
    

    
    Environ Health Prev Med

21. LI YM, Zhao QL, Ogawa R, Mizukami T, et al
    Synergistic inhibition of autophagic flux and induction of apoptosis in cervical cancer cells by Mito-TEMPO and hyperthermia.
    Environ Health Prev Med. 2025;30:67.
    PubMed         Abstract available
    
    

    
    Epidemiol Serv Saude

22. FREITAS AKMSO, Camargo JDAS, Souza ATB, Pontes THA, et al
    Sociodemographic and clinical factors associated with delayed diagnosis of cervical cancer: a cross-sectional study, Brazil, 2016-2020.
    Epidemiol Serv Saude. 2025;34:e20240764.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

23. KIM S, Kwon G, Kim H, Yun H, et al
    Full-term delivery after antepartum vaginal myomectomy for prolapsed myoma causing uterus distortion: A case report and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2025;313:114580.
    PubMed         Abstract available
    
    
24. KEERTHANA A, Anantharaju A, Ansar PTM, Kala, et al
    Real-time detection of premalignant cervical lesion using Artificial Intelligence (AI) model in multispectral imaging system.
    Eur J Obstet Gynecol Reprod Biol. 2025;313:114579.
    PubMed         Abstract available
    
    

    
    Front Immunol

25. DONG Y, Zhang X, Zhao J, Hou Q, et al
    Glycan dysregulation as one of major metabolic subtypes is associated with TERC overexpression and poor outcomes in cervical cancer.
    Front Immunol. 2025;16:1585647.
    PubMed         Abstract available
    
    

    
    Front Oncol

26. LIU C, Li X, Deng Y
    Case Report: Immune-mediated acute liver failure induced by tislelizumab in a patient with advanced cervical cancer.
    Front Oncol. 2025;15:1604601.
    PubMed         Abstract available
    
    
27. CUI N, Zhang Y, Zhang Y, Wang L, et al
    TRIM31 acts as an intermediate molecule in the process by which Snai2 impairs the proliferation of cervical cancer cells.
    Front Oncol. 2025;15:1537991.
    PubMed         Abstract available
    
    
28. XIE C, Liu H, Huang D, Zhao G, et al
    Case Report: Cervical cancer masquerading as ovarian tumor: diagnostic challenges in a case with severe pyometra-pyocolpos complex.
    Front Oncol. 2025;15:1647366.
    PubMed         Abstract available
    
    
29. WANG X, Wang C, Zong D, Zhu B, et al
    First-line treatment with cadonilimab plus paclitaxel-platinum +/- bevacizumab for persistent, recurrent, or metastatic cervical cancer: a retrospective real-world study.
    Front Oncol. 2025;15:1634779.
    PubMed         Abstract available
    
    
30. SHI P, Zhang W, Yao Q, Yuan Z, et al
    CS Ratio is an immune-related prognostic biomarker for cervical cancer.
    Front Oncol. 2025;15:1547529.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

31. FU X, Zhang Q, Wagner AL, Zhou W, et al
    Cost-effectiveness and epidemiological impact of gender-neutral vaccination against human papillomavirus in economically developed metropolises of Beijing, Shanghai, and Guangzhou, China.
    Hum Vaccin Immunother. 2025;21:2557092.
    PubMed         Abstract available
    
    

    
    Indian J Clin Biochem

32. LI Z, Wang H, Yang R, Jin X, et al
    Plasma-Derived Exosomal tRF-Phe-GAA-001 and tRF-Gly-GCC-037 as Novel Diagnostic Biomarkers for Cervical Cancer.
    Indian J Clin Biochem. 2025;40:683-690.
    PubMed         Abstract available
    
    

    
    Int J Cancer

33. LIU Z, Tong X
    Comments on "HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis".
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70130.
    PubMed        
    
    
34. LIU H, Zou Z, Zhang L
    Reply to 'Comments on "HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis"'.
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70129.
    PubMed        
    
    
35. CASTANEDA KM, Vermeulen KM, van der Aa M, Schuuring E, et al
    Trends in cervical cancer incidence in the Netherlands: A join-point and age-period-cohort analysis (1989-2023).
    Int J Cancer. 2025 Sep 8. doi: 10.1002/ijc.70134.
    PubMed         Abstract available
    
    

    
    Int J Gen Med

36. LI Y, Cai L, Zhou J, Zhang X, et al
    RCN1 Binds KIF14 and Promotes the Malignant Growth of Cervical Cancer Through the PI3K-AKT Pathway.
    Int J Gen Med. 2025;18:5047-5062.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

37. ISMAIL M, Refky B, Mostafa N, Elazab M, et al
    From silence to action: Egypt's path to national cervical cancer prevention.
    Int J Gynecol Cancer. 2025 Aug 26:102121. doi: 10.1016/j.ijgc.2025.102121.
    PubMed        
    
    

    
    Int J Radiat Oncol Biol Phys

38. PAI V, Wairkar T, Menon S, Chaudhari S, et al
    PD-L1 expression in locally advanced cervical cancer: A pilot cross clone comparison study.
    Int J Radiat Oncol Biol Phys. 2025 Sep 4:S0360-3016(25)06207.
    PubMed         Abstract available
    
    

    
    IUBMB Life

39. WANG W, Deng Y, Feng Y, Chen R, et al
    Unveiling Gamma-Interferon-Inducible Lysosomal Thiol Reductase (IFI30) as a Regulator of Macrophage Polarization and Prognostic Biomarker by Multi-Transcriptome Analysis in Cervical Cancer.
    IUBMB Life. 2025;77:e70056.
    PubMed         Abstract available
    
    

    
    J Biomed Inform

40. ATLAS SJ, Burdick TE, Wright A, Zhao W, et al
    Comparing clinical decision support systems for improving follow-up of abnormal cervical cancer screening test results.
    J Biomed Inform. 2025 Sep 9:104908. doi: 10.1016/j.jbi.2025.104908.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

41. M EL-DOUSHY A, Attalla EM, Ibrahim IH, El-Sayed SM, et al
    Dosimetry evaluation and uncertainty analysis of Cobalt-60 HDR brachytherapy for cervical cancer in resource-limited settings.
    J Cancer Res Clin Oncol. 2025;151:247.
    PubMed         Abstract available
    
    

    
    J Christ Nurs

42. MINCHEW LA
    Self-Blame Attribution: Concept Analysis and Application to HPV-Related Cancers.
    J Christ Nurs. 2025;42:216-223.
    PubMed         Abstract available
    
    

    
    J Clin Virol

43. OSTRBENK A, Pedersen H, Poljak M, Bonde J, et al
    The Allplex HPV HR Detection assay fulfils international guideline requirements for primary cervical screening on SurePath samples and qualifies as a second-generation HPV comparator test.
    J Clin Virol. 2025;180:105853.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

44. CEN Y, Tu M, Zhang Y, Ren Y, et al
    A novel non-invasive mRNA-lncRNA biomarker panel for accurate prediction of cervical squamous cell carcinoma and adenocarcinoma.
    J Gynecol Oncol. 2025;36:e81.
    PubMed         Abstract available
    
    

    
    J Infect Dev Ctries

45. CELA M, Gjata E, Sinaj E, Ndreu V, et al
    The influence of parents' knowledge on HPV vaccine uptake - evidence from Albania.
    J Infect Dev Ctries. 2025;19:1231-1238.
    PubMed         Abstract available
    
    

    
    J Int Med Res

46. ZHU H, Zhu H, Bao Y
    Multiple injections of indocyanine green for improving the outcomes of lymphatic-venous anastomosis reconstruction of lymphatic return under microscopy: A case report.
    J Int Med Res. 2025;53:3000605251375258.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Can

47. JIANG H, Chen X
    Vulvar cancer combined with cervical cancer.
    J Obstet Gynaecol Can. 2025 Sep 10:103105. doi: 10.1016/j.jogc.2025.103105.
    PubMed        
    
    

    
    J Proteome Res

48. HAO Y, Liu Q, Wang B, Zhang W, et al
    Proteomics-Based Mapping of the Lymph Node Metastasis Landscape in Cervical Cancer.
    J Proteome Res. 2025 Sep 11. doi: 10.1021/acs.jproteome.5c00570.
    PubMed         Abstract available
    
    

    
    J Relig Health

49. BAKAN ABS, Aslan G, Basaran F
    An Investigation of the Effect of Education Interventions Given to Women in Turkey with Religious Orientation on Cervical Cancer and Pap Smear Test Health Beliefs.
    J Relig Health. 2025 Sep 7. doi: 10.1007/s10943-025-02435.
    PubMed         Abstract available
    
    

    
    J Womens Health (Larchmt)

50. ZANWAR PP
    Cervical Cancer Screening: Perspectives from an Interdisciplinary Lens to Inform Future Research, Practice, Policy, and Intervention Strategies.
    J Womens Health (Larchmt). 2025 Sep 8. doi: 10.1177/15409996251370876.
    PubMed        
    
    
51. HARPER DM, Anderson PF, James LN, Alves M, et al
    A Scoping Review of Women with Physical Disabilities and Cervical Cancer Screening.
    J Womens Health (Larchmt). 2025 Sep 8. doi: 10.1177/15409996251374587.
    PubMed         Abstract available
    
    

    
    JAMA Netw Open

52. DAMGACIOGLU H, Curtis C, Sonawane K, Clifford G, et al
    Anal Cancer Incidence Among Women With a History of Cervical Cancer by Age and Time Since Diagnosis.
    JAMA Netw Open. 2025;8:e2531362.
    PubMed        
    
    

    
    JCO Glob Oncol

53. OKUNADE KS, Fayinto AI, Adekanye TV, Allsop MJ, et al
    Randomized Controlled Trial of Impact of Mobile Health Technologies on Human Papillomavirus Vaccination Uptake in Mothers of Vaccine-Eligible Girls in Lagos, Nigeria (mHealth-HPVac).
    JCO Glob Oncol. 2025;11:e2500150.
    PubMed         Abstract available
    
    

    
    JMIR Cancer

54. LI S, Guo C, Fang Y, Qiu J, et al
    Machine Learning for Preoperative Assessment and Postoperative Prediction in Cervical Cancer: Multicenter Retrospective Model Integrating MRI and Clinicopathological Data.
    JMIR Cancer. 2025;11:e69057.
    PubMed         Abstract available
    
    

    
    Kaohsiung J Med Sci

55. GAO Y, Zou T
    Hypoxia Triggers ALYREF-Mediated m(5)C Methylation of KIF20A to Activate KIF20A/BUB1 for Generating Ferroptosis Resistance in Cervical Cancer Cells.
    Kaohsiung J Med Sci. 2025 Sep 7:e70093. doi: 10.1002/kjm2.70093.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

56. CHEN Z, Zhang L, Li D, Zhu R, et al
    Treatment of advanced cervical cancer with Cinobufacini and Paclitaxel-Cisplatin combination: A meta-analysis.
    Medicine (Baltimore). 2025;104:e44146.
    PubMed         Abstract available
    
    

    
    Nutr Clin Pract

57. TIAN M, Yuan Z, Wang H, Liu T, et al
    The cachexia index as a prognostic indicator in patients with cervical cancer treated with radiotherapy: A retrospective study.
    Nutr Clin Pract. 2025 Sep 10. doi: 10.1002/ncp.70032.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

58. TERGAS AI, Einstein MH
    The Future of Cervical Cancer Screening Is Now.
    Obstet Gynecol. 2025;146:3-5.
    PubMed        
    
    

    
    Oncol Lett

59. REN L, Zhang J, Yang J, Ji L, et al
    YTHDC2 inhibits HPV-positive cervical cancer growth by suppressing SLC7A11 in a ferroptosis-dependent manner.
    Oncol Lett. 2025;30:498.
    PubMed         Abstract available
    
    

    
    Open Med (Wars)

60. WU J, Xu Q, Huang H, Pang Y, et al
    Risk and prognosis for brain metastasis in primary metastatic cervical cancer patients: A population-based study.
    Open Med (Wars). 2025;20:20251165.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

61. NIYOTEKA S, Rouhi R, Laurent PA, Achkar S, et al
    GAN-based standardization of MR images: a promising approach for the development of multicentre radiomic models.
    Phys Med Biol. 2025;70.
    PubMed         Abstract available
    
    

    
    PLOS Glob Public Health

62. ADHIAMBO HF, Owidi E, Okello P, Coe M, et al
    Barriers and facilitators to implementing a single-visit, screen-and-treat approach with thermal ablation for cervical cancer prevention in Kenya.
    PLOS Glob Public Health. 2025;5:e0005166.
    PubMed         Abstract available
    
    
63. BILALAGA MM, Gaddipati G, Devkota A, Vasireddy R, et al
    HPV knowledge and non-adherence to cervical cancer screening before and following the COVID-19 pandemic in the United States.
    PLOS Glob Public Health. 2025;5:e0004800.
    PubMed         Abstract available
    
    

    
    PLoS One

64. OLUBODUN T, Olaniran A, Awowole IO, Ohazurike E, et al
    Practice of opportunistic cervical cancer screening and health education among health workers in Ogun State, Nigeria: A qualitative study of barriers and facilitators.
    PLoS One. 2025;20:e0316883.
    PubMed         Abstract available
    
    
65. MWANGI JH, Mbeje PN, Mtshali GN
    Exploring the roles of male partners in the transmission, prevention and control of cervical cancer in Central Kenya: A qualitative study.
    PLoS One. 2025;20:e0324575.
    PubMed         Abstract available
    
    
66. JAFRIN S, Aziz MA, Barek MA, Reza MS, et al
    Association of missense variant DCLRE1B rs3761936 with breast and cervical cancer risk-A case-control study.
    PLoS One. 2025;20:e0331492.
    PubMed         Abstract available
    
    
67. WYNN A, Harris D, Modest A, Reyes MF, et al
    Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana.
    PLoS One. 2025;20:e0328803.
    PubMed         Abstract available
    
    
68. KHIRUDDIN K, Mustafa WA, Islam MA, Jamaludin KR, et al
    Comparative analysis of cervical cancer classification of DPAGCHE-enhanced Pap smear images using convolutional neural network models.
    PLoS One. 2025;20:e0330103.
    PubMed         Abstract available
    
    

    
    Pol Merkur Lekarski

69. HRYNEVYCH OY
    Human papillomavirus: problems and prospects for women's reproductive health (systematic review).
    Pol Merkur Lekarski. 2025;53:546-554.
    PubMed         Abstract available
    
    

    
    Psychooncology

70. CHONA EZ, Gosse RA, Msengi EA, Aruldhas TP, et al
    Life Experiences of Women Diagnosed With Cervical Cancer in Sub-Saharan Africa: A Systematic Review of Qualitative Studies.
    Psychooncology. 2025;34:e70280.
    PubMed         Abstract available
    
    

    
    Rep Pract Oncol Radiother

71. PATRE P, Verma D
    Deep dive into deep learning methods for cervical cancer detection and classification.
    Rep Pract Oncol Radiother. 2025;30:396-416.
    PubMed         Abstract available
    
    
72. PATRE P, Verma D
    Optimizing cervical cancer diagnosis with accurate cell classification using modified HDFF.
    Rep Pract Oncol Radiother. 2025;30:316-331.
    PubMed         Abstract available
    
    

    
    Rev Cuid

73. DE OLIVEIRA SERRA TOCHETTO L, Meimei Brevidelli M, Rodrigues Santos T, Samora de Almeida M, et al
    Quality of cervical cancer screening in a Brazilian sample: cross-sectional study.
    Rev Cuid. 2025;16:e3597.
    PubMed         Abstract available
    
    

    
    Strahlenther Onkol

74. AUTORINO R, Macchia G, Russo L, Dinapoli N, et al
    Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?
    Strahlenther Onkol. 2025 Sep 12. doi: 10.1007/s00066-025-02463.
    PubMed         Abstract available
    
    

    
    Support Care Cancer

75. DUAN S, Su Y, Niu Q, Wei J, et al
    Construction and implementation of a nursing intervention program based on supportive care theory for cervical cancer patients receiving postoperative concurrent chemoradiotherapy.
    Support Care Cancer. 2025;33:845.
    PubMed         Abstract available
    
    

    
    Womens Health (Lond)

76. CHEN R, Ye C, Li Y, Lin Z, et al
    Analysis of follow-up outcomes in patients with cervical histologic low-grade squamous intraepithelial lesion preceded by serious cytology and repeated diagnosis for at least 2 years.
    Womens Health (Lond). 2025;21:17455057251374504.
    PubMed         Abstract available
    
    

    
    Womens Health Issues

77. OLSON A, Fuzzell L, Brownstein NC, Fontenot HB, et al
    Factors Associated With Guideline-Concordant Cervical Cancer Screening Exit: A Mixed Methods Study.
    Womens Health Issues. 2025 Sep 8:S1049-3867(25)00102.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.